Serina Therapeutics (SER) Preferred Shares (2018 - 2025)
Serina Therapeutics' (SER) quarterly Preferred Shares came in at $4.9 million in Q4 2025, little changed quarter-over-quarter from $4.9 million in Q3 2025.
Analysis
Serina Therapeutics (SER) Preferred Shares (2018 - 2025) Analysis & Trends
Serina Therapeutics has disclosed Preferred Shares across 4 years of filings, most recently posting $4.9 million for Q4 2025.
- In Q4 2025, Preferred Shares changed N/A year-over-year to $4.9 million; the TTM figure through Dec 2025 stood at $4.9 million (changed N/A YoY), while the FY2025 annual figure was $4.9 million, changed N/A from the prior year.
- Preferred Shares came in at $4.9 million for Q4 2025 at Serina Therapeutics, roughly flat from $4.9 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $5.0 million in Q1 2024 to a low of $4.9 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Serina Therapeutics | 40.47 Mn | 17.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.94 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | 4.94 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Mar 31, 2019 | 5.00 Mn |
| Dec 31, 2018 | 5.00 Mn |